Evidence map›Paper›PMID 35570817›Full record

ArticleACS macro letters2022

Cascade Alternating Metathesis Cyclopolymerization of Diynes and Dihydrofuran.

Xuelin Sui, Will R Gutekunst

Registry-linked trialAbstract read
In one paragraph

Article in ACS macro letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07023536 (Evaluation of the Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07023536 recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of the Effectiveness of a Cardiac Telerehabilitation Program in Chronic Heart Failure

TypeobservationalSponsorUniversity of SalernoRan2025 to 2026Enrolled205ConditionsHeart FailureArmsTELEREHABILITATION-YES, TELEREHABILITATION-NO
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ring-Opening Metathesis Polymerization of 1,2-Dihydroazete Derivatives.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xuelin SuiSchool of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332, United States.
Will R GutekunstSchool of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332, United States.ORCID 0000-0002-2427-4431

Funding

A Versatile Polymer Platform for Biomedical ApplicationsR35GM133784 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI GUTEKUNST, WILL RYAN · 2019 to 2023
$1.8M
NIGMS NIH HHS R35 GM133784
6 · The paper itself

Abstract

Ruthenium alkoxymethylidene complexes have recently come into view as competent species for metathesis copolymerization reactions when coupled with appropriate comonomer targets. Here, we explore the ability of Fischer-type carbenes to participate in cascade alternating metathesis cyclopolymerization (CAMC) through facile terminal alkyne addition. The combination of diyne monomers and an equal feed ratio of low-strain dihydrofuran leads to a controlled chain-growth copolymerization with high degrees of alternation (>97% alternating diads) and produces degradable polymer materials with low dispersities and targetable molecular weights. When combined with enyne monomers, this method is amenable to the synthesis of alternating diblock copolymers that can be fully degraded to short oligomer fragments under aqueous acidic conditions. This work furthers the potential for the generation of functional metathesis materials via Fischer-type ruthenium alkylidenes.

Indexed as

RutheniumAlkynesDiynesPolymerizationPolymersAlkynesDiynesPolymersRuthenium

Identifiers

PMID35570817
PMCPMC9173669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.